SAT-371 No amino acid substitution in HBV PreS1, HDAg, or NTCP associated with suboptimal response to bulevirtide in combination with pegylated interferon alfa-2a treatment in participants with chronic hepatitis delta: results from MYR204 a phase 2b study
Authors
Jing Wang,
Silvia ChangSimin Xu,
Ross Martin,
Thomas Aeschbacher,
Savrina Manhas,
Roberto Mateo,
Lindsey May,
Dong Han,
Tahmineh Yazdi,
Caleb Marceau,
Christopher Richards,
Pui Ho,
Chunfeng Li,
C Martínez,
Nadine Peinovich,
Andrew Lopez,
Dmitry Manuilov,
Renée-Claude Mercier,
Audrey Lau,
Tarik Asselah,
Fabien Zoulim,
Evguenia Maiorova,
Hongmei Mo +22 authors
,
Celia Martínez Tip Tip